ID29543A - TURUNAN-TURUNAN OKSAZOL DAN TIAZOL YANG DISUBSTITUSI SEBAGAI AKTIVATOR-AKTIVATOR τhPPAR DAN αhPPAR - Google Patents

TURUNAN-TURUNAN OKSAZOL DAN TIAZOL YANG DISUBSTITUSI SEBAGAI AKTIVATOR-AKTIVATOR τhPPAR DAN αhPPAR

Info

Publication number: ID29543A
Authority: ID; Indonesia
Prior art keywords: τhppar; αhppar; osazol; tiazol; activators
Prior art date: 1998-08-07

Application number

IDW20010541A

Other languages

English (en)

Inventor

John L Collins

Milana Dazube

Jeffrey A Oplinger

Timothy M Willson

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

1999-08-05

Publication date

2001-09-06

1999-08-05 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-09-06 Publication of ID29543A publication Critical patent/ID29543A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

IDW20010541A 1998-08-07 1999-08-05 TURUNAN-TURUNAN OKSAZOL DAN TIAZOL YANG DISUBSTITUSI SEBAGAI AKTIVATOR-AKTIVATOR τhPPAR DAN αhPPAR ID29543A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9817118.4A GB9817118D0 (en)	1998-08-07	1998-08-07	Pharmaceutical compounds

Publications (1)

Publication Number	Publication Date
ID29543A true ID29543A (id)	2001-09-06

Family

ID=10836805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010541A ID29543A (id)	1998-08-07	1999-08-05	TURUNAN-TURUNAN OKSAZOL DAN TIAZOL YANG DISUBSTITUSI SEBAGAI AKTIVATOR-AKTIVATOR τhPPAR DAN αhPPAR

Country Status (31)

Country	Link
US (1)	US6498174B1 (id)
EP (1)	EP1102757B1 (id)
JP (1)	JP2002522426A (id)
KR (1)	KR20010085340A (id)
CN (1)	CN1321152A (id)
AP (1)	AP2001002066A0 (id)
AR (1)	AR020001A1 (id)
AT (1)	ATE264313T1 (id)
AU (1)	AU5731099A (id)
BR (1)	BR9912866A (id)
CA (1)	CA2339773A1 (id)
CO (1)	CO5070570A1 (id)
CZ (1)	CZ2001490A3 (id)
DE (1)	DE69916457T2 (id)
EA (1)	EA200100105A1 (id)
EE (1)	EE200100074A (id)
ES (1)	ES2220110T3 (id)
GB (1)	GB9817118D0 (id)
HR (1)	HRP20010095A2 (id)
HU (1)	HUP0103469A3 (id)
ID (1)	ID29543A (id)
IL (1)	IL141248A0 (id)
IS (1)	IS5840A (id)
MA (1)	MA26668A1 (id)
NO (1)	NO20010628L (id)
PE (1)	PE20000947A1 (id)
PL (1)	PL345882A1 (id)
SK (1)	SK1962001A3 (id)
TR (1)	TR200100372T2 (id)
WO (1)	WO2000008002A1 (id)
ZA (1)	ZA200100983B (id)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1206457T3 (da) *	1999-08-27	2004-02-16	Lilly Co Eli	Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
EP1939188A1 (en) *	1999-09-22	2008-07-02	Bristol-Myers Squibb Company	Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents
US6414002B1 (en)	1999-09-22	2002-07-02	Bristol-Myers Squibb Company	Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
TW200528436A (en) *	1999-09-22	2005-09-01	Bristol Myers Squibb Co	Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
GB0002667D0 (en) *	2000-02-04	2000-03-29	Glaxo Group Ltd	medicamesnts
GB0031103D0 (en) *	2000-12-20	2001-01-31	Glaxo Group Ltd	Chemical compounds
US20040072838A1 (en)	2000-12-20	2004-04-15	Pierette Banker	Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
US7241785B2 (en)	2001-03-23	2007-07-10	Takeda Pharmaceutical Company Limited	Five-membered heterocyclic alkanoic acid derivative
GB0111523D0 (en) *	2001-05-11	2001-07-04	Glaxo Group Ltd	Chemical compounds
ME01310B (me) *	2001-05-15	2011-10-10	Hoffmann La Roche	Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa-1-gama aktivatori u lečenju dijabetesa
WO2002096880A1 (en) *	2001-05-29	2002-12-05	Kyoto Pharmaceutical Industries, Ltd.	Novel heterocyclic compound and medicinal use thereof
KR100874677B1 (ko)	2001-05-29	2008-12-18	교토 야쿠힝 고교 가부시키가이샤	신규 복소환 유도체 및 그 의약 용도
US6861440B2 (en)	2001-10-26	2005-03-01	Hoffmann-La Roche Inc.	DPP IV inhibitors
TW200300681A (en) *	2001-11-12	2003-06-16	Ono Pharmaceutical Co	Carboxylic acid derivative compound and medicament containing same as active ingredient
CA2473207A1 (en)	2002-01-17	2003-07-24	Toa Eiyo Ltd.	Halogenobenzylaminopropionic acid derivatives
US6716842B2 (en)	2002-04-05	2004-04-06	Warner-Lambert Company, Llc	Antidiabetic agents
US20050119314A1 (en) *	2002-04-05	2005-06-02	Sankyo Company, Limited	Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
KR100474202B1 (ko) *	2002-05-04	2005-03-08	강헌중	티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체
ATE372990T1 (de)	2002-07-03	2007-09-15	Hoffmann La Roche	Oxazolderivat und deren verwendung als insulinsensibilisatoren
AU2003259131A1 (en)	2002-07-09	2004-01-23	Bristol-Myers Squibb Company	Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
CN100475810C (zh) *	2002-08-30	2009-04-08	霍夫曼-拉罗奇有限公司	作为PPARα和PPARγ激动剂的新型2-芳基噻唑化合物
NZ537979A (en)	2002-09-12	2007-08-31	Hoffmann La Roche	N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
TWI343915B (en) *	2002-10-07	2011-06-21	Hoffmann La Roche	Chirale ppar agonists
MXPA05005445A (es)	2002-11-25	2005-08-26	Hoffmann La Roche	Derivados de indolilo.
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
US7192970B2 (en)	2002-11-26	2007-03-20	Chipscreen Biosciences, Ltd.	Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
US7268157B2 (en) *	2002-11-26	2007-09-11	Shenzhen Chipscreen Biosciences, Ltd.	Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
BRPI0411713B8 (pt)	2003-06-20	2021-05-25	Hoffmann La Roche	compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
BRPI0411509A (pt)	2003-06-20	2006-07-25	Hoffmann La Roche	compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
UA85711C2 (ru)	2004-05-06	2009-02-25	Зе Регентс Оф Зе Юниверсити Оф Калифорния	Замещенные енаминоны, их производные и их применение
CN100467456C (zh) *	2004-05-24	2009-03-11	北京摩力克科技有限公司	作为hPPARα和/或hPPARγ激活剂的α-哌嗪取代的苯丙酸衍生物
CN100436430C (zh) *	2004-05-24	2008-11-26	北京摩力克科技有限公司	作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物
CN100344618C (zh)	2004-05-24	2007-10-24	北京摩力克科技有限公司	作为hPPARα和hPPARγ激动剂的N－芳丙烯酰基取代的酪氨酸衍生物
CN1896069B (zh) *	2005-07-15	2011-10-05	中国科学院上海药物研究所	一类取代噻唑-4酮化合物、制备方法和用途
CN101007790B (zh) *	2006-01-27	2011-03-30	北京摩力克科技有限公司	草氨酸衍生物、其制备方法和医药用途
JP4999923B2 (ja) *	2006-06-13	2012-08-15	中国科学院上海薬物研究所	複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物
GB0719180D0 (en) *	2007-10-02	2007-11-14	Cambrex Karlskoga Ab	New process
EP2135865A1 (de)	2008-06-17	2009-12-23	Bayer CropScience AG	Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
EP2194052A1 (de)	2008-12-06	2010-06-09	Bayer CropScience AG	Substituierte 1-(Thiazolyl)- und 1-(Isothiazolyl)pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
WO2011073098A1 (de)	2009-12-15	2011-06-23	Bayer Cropscience Ag	1-(heteroaryl)-pyrazol-4-yl-essigsäuren, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren
US20120094959A1 (en)	2010-10-19	2012-04-19	Bonnie Blazer-Yost	Treatment of cystic diseases
WO2022052982A1 (zh) *	2020-09-14	2022-03-17	昭明泽康（北京）生物医药科技有限公司	PPARα（过氧化物酶体增殖物激活受体α）配体在制备药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089514A (en) *	1990-06-14	1992-02-18	Pfizer Inc.	3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US6062509A (en)	1994-12-23	2000-05-16	Hexcel Corporation	Retrofit centerline luggage bin assemblies compatible with existing aircraft bin supports
JPH08325263A (ja)	1995-05-31	1996-12-10	Sumitomo Metal Ind Ltd	新規２−アミノ−３−フェニルプロピオン酸誘導体
GB9604242D0 (en) *	1996-02-28	1996-05-01	Glaxo Wellcome Inc	Chemical compounds
IL128600A0 (en) *	1996-08-19	2000-01-31	Japan Tobacco Inc	Propionic acid derivatives and pharmaceutical compositions containing them

1998
- 1998-08-07 GB GBGB9817118.4A patent/GB9817118D0/en not_active Ceased
1999
- 1999-08-04 CO CO99049333A patent/CO5070570A1/es unknown
- 1999-08-04 AR ARP990103874A patent/AR020001A1/es not_active Application Discontinuation
- 1999-08-05 EP EP99944335A patent/EP1102757B1/en not_active Expired - Lifetime
- 1999-08-05 US US09/762,445 patent/US6498174B1/en not_active Expired - Fee Related
- 1999-08-05 TR TR2001/00372T patent/TR200100372T2/xx unknown
- 1999-08-05 AT AT99944335T patent/ATE264313T1/de not_active IP Right Cessation
- 1999-08-05 CA CA002339773A patent/CA2339773A1/en not_active Abandoned
- 1999-08-05 ES ES99944335T patent/ES2220110T3/es not_active Expired - Lifetime
- 1999-08-05 BR BR9912866-7A patent/BR9912866A/pt not_active Application Discontinuation
- 1999-08-05 AP APAP/P/2001/002066A patent/AP2001002066A0/en unknown
- 1999-08-05 AU AU57310/99A patent/AU5731099A/en not_active Abandoned
- 1999-08-05 IL IL14124899A patent/IL141248A0/xx unknown
- 1999-08-05 EA EA200100105A patent/EA200100105A1/ru unknown
- 1999-08-05 JP JP2000563635A patent/JP2002522426A/ja active Pending
- 1999-08-05 CN CN99811640A patent/CN1321152A/zh active Pending
- 1999-08-05 PE PE1999000790A patent/PE20000947A1/es not_active Application Discontinuation
- 1999-08-05 ID IDW20010541A patent/ID29543A/id unknown
- 1999-08-05 SK SK196-2001A patent/SK1962001A3/sk unknown
- 1999-08-05 HR HR20010095A patent/HRP20010095A2/hr not_active Application Discontinuation
- 1999-08-05 MA MA25716A patent/MA26668A1/fr unknown
- 1999-08-05 DE DE69916457T patent/DE69916457T2/de not_active Expired - Lifetime
- 1999-08-05 WO PCT/EP1999/005666 patent/WO2000008002A1/en not_active Ceased
- 1999-08-05 CZ CZ2001490A patent/CZ2001490A3/cs unknown
- 1999-08-05 EE EEP200100074A patent/EE200100074A/xx unknown
- 1999-08-05 HU HU0103469A patent/HUP0103469A3/hu unknown
- 1999-08-05 KR KR1020017001617A patent/KR20010085340A/ko not_active Withdrawn
- 1999-08-05 PL PL99345882A patent/PL345882A1/xx not_active Application Discontinuation
2001
- 2001-02-05 ZA ZA200100983A patent/ZA200100983B/en unknown
- 2001-02-05 IS IS5840A patent/IS5840A/is unknown
- 2001-02-06 NO NO20010628A patent/NO20010628L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20010628L (no)	2001-04-06
HUP0103469A2 (hu)	2002-01-28
ATE264313T1 (de)	2004-04-15
EA200100105A1 (ru)	2001-08-27
DE69916457D1 (de)	2004-05-19
IL141248A0 (en)	2002-03-10
AP2001002066A0 (en)	2001-03-31
US6498174B1 (en)	2002-12-24
PL345882A1 (en)	2002-01-14
SK1962001A3 (en)	2001-11-06
BR9912866A (pt)	2001-10-30
NO20010628D0 (no)	2001-02-06
AU5731099A (en)	2000-02-28
EP1102757B1 (en)	2004-04-14
PE20000947A1 (es)	2000-09-22
AR020001A1 (es)	2002-03-27
EE200100074A (et)	2002-06-17
DE69916457T2 (de)	2005-04-14
GB9817118D0 (en)	1998-10-07
TR200100372T2 (tr)	2001-09-21
KR20010085340A (ko)	2001-09-07
EP1102757A1 (en)	2001-05-30
IS5840A (is)	2001-02-05
CA2339773A1 (en)	2000-02-17
ZA200100983B (en)	2002-03-05
JP2002522426A (ja)	2002-07-23
ES2220110T3 (es)	2004-12-01
CN1321152A (zh)	2001-11-07
HRP20010095A2 (en)	2002-02-28
CO5070570A1 (es)	2001-08-28
MA26668A1 (fr)	2004-12-20
HUP0103469A3 (en)	2002-08-28
WO2000008002A1 (en)	2000-02-17
CZ2001490A3 (cs)	2001-08-15

Publication	Publication Date	Title
MA26668A1 (fr)	2004-12-20	ACTIVATEURS DE hPPARy ET hPPARa
ID29591A (id)	2001-09-06	Senyawa-senyawa kuinolina dan kuinoksalina
ATE446389T1 (de)	2009-11-15	Enzymgemisch
ID22889A (id)	1999-12-16	Komposisi kopolimer etilena dan penggunaannya
ID25651A (id)	2000-10-19	Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait
ID16862A (id)	1997-11-20	Komposisi-komposisi elastomer dan metoda-metoda pembuatannya
ID28728A (id)	2001-06-28	Komposisi dan proses pengkrepan
ID19422A (id)	1998-07-09	Piridina dan bifenil tersubstitusi
ID22957A (id)	1999-12-23	Senyawa dan penggunaannya
ID28846A (id)	2001-07-05	2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ATE255628T1 (de)	2003-12-15	Bleichaktivator-granulate
ID23684A (id)	2000-05-11	Komposisi-polimer-organoclay dan pembuatannya
ID24196A (id)	2000-07-13	Komposisi dan penggunaan
ID22956A (id)	1999-12-23	Sintesa disulfida dan polisulfida organik
DE69910714D1 (de)	2003-10-02	Pflanzenaktivierungsmittel
ID20303A (id)	1998-11-26	Komposisi surfaktan
DE19981911T1 (de)	2001-01-18	Gasbildende Zusammensetzung
ID16889A (id)	1997-11-20	Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID21764A (id)	1999-07-22	Komposisi-komposisi yang mengandung antijamur dan fosfolipid
DE19981910T1 (de)	2001-01-18	Gasbildende Zusammensetzung
ID23258A (id)	2000-04-05	Penarik pemberian-menyilang dan metodenya
ID20441A (id)	1998-12-17	Komposisi surfaktan
DE59915059D1 (de)	2009-09-17	Bleichaktivatorgranulate
FI972330A0 (fi)	1997-06-02	Biasspaenningsstyrda parallela aktivkomponenter
ZA9810771B (en)	1999-05-26	Method and compositions useful for the activation of silent transgenes